Items where Author is "Ghadiany, M."
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 1.
Article
(2022) Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial. BMC Cancer. p. 10.